Last reviewed · How we verify

NCT05051514: OSASRehab

Physical Status of OSA Patients

Completed Last updated 5 July 2022
What this trial tests

trial testing Evaluation in Obstructive Sleep Apnea Syndrome in 84 participants. Completed in 30 May 2022.

Timeline
18 April 2021
Primary endpoint
30 April 2022
30 May 2022

Quick facts

Lead sponsorOkan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment84
Start date18 April 2021
Primary completion30 April 2022
Estimated completion30 May 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Okan University

Who can join

18 and older, any sex, with Obstructive Sleep Apnea Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the differences in postural stability, anxiety/depression, and quality of life of the patients according to the severity of Obstructive Sleep Apnea Syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Evaluation

Trials testing the same drug.

Other recruiting trials for Obstructive Sleep Apnea Syndrome

Currently open trials in the same condition.

Other Okan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05051514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing